Does TOFACITINIB Cause Dementia alzheimer's type? 143 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Dementia alzheimer's type have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
143
Reports of Dementia alzheimer's type with TOFACITINIB
0.1%
of all TOFACITINIB reports
15
Deaths
12
Hospitalizations
How Dangerous Is Dementia alzheimer's type From TOFACITINIB?
Of the 143 reports, 15 (10.5%) resulted in death, 12 (8.4%) required hospitalization.
Is Dementia alzheimer's type Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 143 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Dementia alzheimer's type?
RIVASTIGMINE (428)
APIXABAN (362)
ADALIMUMAB (228)
INSULIN GLARGINE (162)
SACUBITRIL\VALSARTAN (158)
LENALIDOMIDE (153)
ETANERCEPT (152)
INSULIN LISPRO (148)
TRIPTORELIN (106)
DONEPEZIL (103)
Which TOFACITINIB Alternatives Have Lower Dementia alzheimer's type Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN